| Literature DB >> 16647712 |
Yang Liu1, Randal D Goff, Dapeng Zhou, Jochen Mattner, Barbara A Sullivan, Archana Khurana, Carlos Cantu, Eugene V Ravkov, Chris C Ibegbu, John D Altman, Luc Teyton, Albert Bendelac, Paul B Savage.
Abstract
CD1d presentation of alpha-galactosyl ceramides to natural killer T cells has been a focal point of the study of regulatory T cells. KRN7000, an alpha-galactosyl ceramide originally generated from structure activity studies of antitumor properties of marine sponge glycolipids, is currently the most commonly used agonist ligand and is used to stain NKT cells. However, this glycolipid suffers from poor solubility and availability. We have developed an alpha-galactosyl ceramide with improved solubility over KRN7000 that effectively stains NKT cells, both mouse and human, and stimulates cytokine release at low concentrations.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16647712 DOI: 10.1016/j.jim.2006.02.009
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303